BioWorld Asia

April 30, 2003

View Archived Issues

Diatos Licenses European Rights To Cancer Drug From Medarex

PARIS - Diatos SA and Medarex Inc. signed a licensing agreement giving Diatos exclusive European rights to develop and commercialize a potential new cancer treatment. (BioWorld International) Read More

Biotech Groups In Norway Unite, Plan To Catch Up With Neighbors

Read More

Genetic Study Of Clotting Enzyme Points To 'Fantastic' Drug Target

Read More

Curnock Cook Investing Again After Forming New €150M Fund

No Abstract Read More

PPL Gives Up Plans On Plant To Manufacture AAT Product

Read More

French Companies, Agency Unite For Effort In America

Read More

Alizyme Eyes Phase III, Alliance Following Renzapride Results

Read More

GenoWay Raises EUR3.3M To Fund Work On Animal, In Vitro Models

Read More

Merck Stops Development Of Celltech PDE-4 Inhibitor

Read More

UK Industry Gathers To Celebrate 50th Anniversary Of DNA Finding

Read More

Other News To Note

Read More